Abstract
The ability of Superparamagnetic Iron Oxide (SPIO) nanoparticles and Poly(Propyleneimine) generation 5 dendrimers (PPI G5) to cooperatively provoke siRNA complexation was investigated in order to develop a targeted, multifunctional siRNA delivery system for cancer therapy. Poly(ethylene glycol) (PEG) coating and cancer specific targeting moiety (LHRH peptide) have been incorporated into SPIO-PPI G5-siRNA complexes to enhance serum stability and selective internalization by cancer cells. Such a modification of siRNA nanoparticles enhanced its internalization into cancer cells and increased the efficiency of targeted gene suppression in vitro. Moreover, the developed siRNA delivery system was capable of sufficiently enhancing in vivo antitumor activity of an anticancer drug (Cisplatin). The proposed approach demonstrates potential for the creation of targeted multifunctional nanomedicine platforms with the ability to deliver therapeutic siRNA specifically to cancer cells in order to prevent severe adverse side effects on healthy tissues and in situ monitoring of the therapeutic outcome using clinically relevant imaging techniques.
Keywords: SPIO nanoparticles, PPI dendrimer, siRNA, Cisplatin, LHRH peptide, imaging, tumor targeting, Magnetic Resonance Imaging, Superparamagnetic Iron Oxide, Polypropyleneimine Generation 5, 2,4,6-Trinitrobenzenesulphonic Acid, 1-octadecene, Sodium Dodecyl Sulfate, amphiphilic polymers, Dynamic Light Scattering, Atomic Force Microscope, luciferase, reverse transcription-polymerase chain reaction, Bicinchoninic Acid
Current Drug Delivery
Title: Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Superparamagnetic Iron Oxide Nanoparticles-Dendrimer Complexes
Volume: 8 Issue: 1
Author(s): Oleh Taratula, Olga Garbuzenko, Ronak Savla, Y. Andrew Wang, Huixin He and Tamara Minko
Affiliation:
Keywords: SPIO nanoparticles, PPI dendrimer, siRNA, Cisplatin, LHRH peptide, imaging, tumor targeting, Magnetic Resonance Imaging, Superparamagnetic Iron Oxide, Polypropyleneimine Generation 5, 2,4,6-Trinitrobenzenesulphonic Acid, 1-octadecene, Sodium Dodecyl Sulfate, amphiphilic polymers, Dynamic Light Scattering, Atomic Force Microscope, luciferase, reverse transcription-polymerase chain reaction, Bicinchoninic Acid
Abstract: The ability of Superparamagnetic Iron Oxide (SPIO) nanoparticles and Poly(Propyleneimine) generation 5 dendrimers (PPI G5) to cooperatively provoke siRNA complexation was investigated in order to develop a targeted, multifunctional siRNA delivery system for cancer therapy. Poly(ethylene glycol) (PEG) coating and cancer specific targeting moiety (LHRH peptide) have been incorporated into SPIO-PPI G5-siRNA complexes to enhance serum stability and selective internalization by cancer cells. Such a modification of siRNA nanoparticles enhanced its internalization into cancer cells and increased the efficiency of targeted gene suppression in vitro. Moreover, the developed siRNA delivery system was capable of sufficiently enhancing in vivo antitumor activity of an anticancer drug (Cisplatin). The proposed approach demonstrates potential for the creation of targeted multifunctional nanomedicine platforms with the ability to deliver therapeutic siRNA specifically to cancer cells in order to prevent severe adverse side effects on healthy tissues and in situ monitoring of the therapeutic outcome using clinically relevant imaging techniques.
Export Options
About this article
Cite this article as:
Taratula Oleh, Garbuzenko Olga, Savla Ronak, Andrew Wang Y., He Huixin and Minko Tamara, Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Superparamagnetic Iron Oxide Nanoparticles-Dendrimer Complexes, Current Drug Delivery 2011; 8(1) . https://dx.doi.org/10.2174/156720111793663642
DOI https://dx.doi.org/10.2174/156720111793663642 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Targeting Mutant KRAS for Anticancer Therapy
Current Topics in Medicinal Chemistry ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology In Silico Modeling for the Design of 2-substitted Benzimidazole Derivatives, and Prediction of Activity as Procaspase-3 Activators and Apoptosis Inducer
Letters in Drug Design & Discovery Cationized Albumin Conjugated Solid Lipid Nanoparticles as Vectors for Brain Delivery of an Anti-Cancer Drug
Current Nanoscience Positron Emission Tomography Imaging of Tumor Hypoxia
Current Medical Imaging CASC15: A Tumor-Associated Long Non-Coding RNA
Current Pharmaceutical Design Current Application of Quantum Dots (QD) in Cancer Therapy: A Review
Mini-Reviews in Medicinal Chemistry The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology MicroRNAs: An Apparent Switch for High-Altitude Pulmonary Edema
MicroRNA Hepatoma-Derived Growth Factor in Carcinogenesis and Cancer Progression
Current Drug Therapy Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases
Current Pharmaceutical Design Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research
Mini-Reviews in Medicinal Chemistry Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy
Current Cancer Drug Targets Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer
Current Bioactive Compounds Corticotropin Releasing Factor (CRF) Peptide Family and their Receptors: Divergent Actions Influencing Human Physiology
Current Genomics Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules
Current Molecular Pharmacology Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents Virtual Screening of Acetylcholinesterase Inhibitors Based on Machine Learning Combined with Molecule Docking Methods
Current Bioinformatics Hybolites Revisited
Recent Patents on Anti-Infective Drug Discovery